肝移植队列中内镜逆行胰胆管造影术后与操作相关的再入院情况
Procedure-related readmissions following endoscopic retrograde cholangiopancreatography in a liver transplant cohort.
作者信息
Gu Jennifer, Zorron Cheng Tao Pu Leonardo, Ng Jonathan, Be Kim H, Vaughan Rhys, Chandran Sujievvan, Efthymiou Marios
机构信息
Medicine, Dentistry and Health Sciences University of Melbourne Parkville Victoria Australia.
Department of Gastroenterology and Hepatology Austin Health Melbourne Victoria Australia.
出版信息
JGH Open. 2024 Oct 3;8(10):e70008. doi: 10.1002/jgh3.70008. eCollection 2024 Oct.
BACKGROUND AND AIM
Data on post-endoscopic retrograde cholangiopancreatography (ERCP) adverse events and readmission rates in liver transplantation (LT) patients remain scarce. This study determined the 30-day procedure-related readmission rate following ERCP in an LT cohort at an Australian tertiary academic center.
METHODS
All unplanned readmissions within 30 days following ERCP in orthotopic LT patients between December 2012 and August 2021 were retrospectively identified. Demographic data, procedure variables, and readmission characteristics were also collected.
RESULTS
Forty-five procedure-related readmissions were identified (3.3%) from a total of 1369 ERCP procedures. This included 33 cases of cholangitis (2.4%), 7 cases of nonspecific abdominal pain (0.5%), 5 cases of mild post-ERCP pancreatitis (0.5%), and 3 cases of bleeding (0.2%). No procedure-related mortality was observed.
CONCLUSION
The procedure-related readmission rate following ERCP in this LT cohort was 3.3%, which is likely lower than comparable studies carried out on the overall population.
背景与目的
关于肝移植（LT）患者内镜逆行胰胆管造影术（ERCP）后不良事件和再入院率的数据仍然很少。本研究确定了澳大利亚一家三级学术中心LT队列中ERCP术后30天与手术相关的再入院率。
方法
回顾性确定2012年12月至2021年8月间原位肝移植患者ERCP术后30天内的所有非计划再入院情况。还收集了人口统计学数据、手术变量和再入院特征。
结果
在总共1369例ERCP手术中，确定了45例与手术相关的再入院（3.3%）。其中包括33例胆管炎（2.4%）、7例非特异性腹痛（0.5%）、5例轻度ERCP术后胰腺炎（0.5%）和3例出血（0.2%）。未观察到与手术相关的死亡。
结论
该LT队列中ERCP术后与手术相关的再入院率为3.3%，这可能低于对总体人群进行的类似研究。
Zotero 插件